Tag : CONTINUOUS GLUCOSE MONITORING

Continuous glucose monitoring has become an essential tool in modern diabetes management, providing insight into glucose patterns and variability not captured by  HbA1c alone. Current evidence indicates that glycemic assessment must extend beyond HbA1c, particularly for individuals with T2D who face an elevated risk of microvascular and cardiometabolic complications.1 Evolving clinical guidance supports a multidimensional approach to glycemia, positioning CGM as a critical instrument for therapy selection, titration, treatment intensification, and individualized lifestyle modification.1 At ATTD-ASIA 2025, Dr. Daphne Gardner from Singapore General Hospital highlighted the practical benefits of CGM in T2D management, emphasizing its role in detecting glycemic excursions, guiding therapy adjustments, and supporting patient-centered care.1